Systemic Lupus Erythematosus ( SLE ) is the most common form of lupus. Widespread inflammation and tissue damage of joints, skin, brain, lungs, kidneys, and blood vessels occur due to the immune system attacking its own healthy tissues. Below are COVID news and research updates that specifically relate to SLE.
A study published recently in the International Journal of Rheumatic Diseases looked to “assess the characteristics of inflammatory rheumatic disease (IRD) patients in Kuwait diagnosed with COVID-19 and the factors linked with hospitalization, complications, and mortality.”
Read More »A study published recently in Nature analyzed the whole-genome sequencing of a 7-year-old child diagnosed with severe lupus. Her genetics were of particular interest due to the fact that such a severe case of lupus with early-onset symptoms is considered rare and strongly indicates a single genetic cause. Their analysis revealed a single-point mutation in the TLR7 gene.
Read More »The findings presented at the American Academy of Dermatology 2022 Annual Meeting showed a definite signal triggering various autoimmune disease risks following infection of the pandemic virus.
Read More »Antiphospholipid autoantibodies can be present in multiple autoimmune diseases, including rheumatoid arthritis, lupus, and ANCA vasculitis. A recent study pinpointed antiphospholipid autoantibodies as a possible culprit in severe blood clotting following a COVID-19 infection.
Read More »